Global preimplantation genetic testing market is anticipated to grow at a significant CAGR of 11.9% during the forecast period (2024-2031). A major factor supporting the growth of the market is the increasing prevalence of genetic disorders and chromosomal abnormalities. As awareness of these conditions grows and technological advancements in genetic testing improve, more individuals and couples are turning to preimplantation genetic testing as a means to identify and mitigate the risk of passing on genetic conditions to their offspring. To meet the demand for advanced testing kit among end-user, in 2023, Thermo Fisher Scientific Inc. introduced two novel Next-Generation Sequencing (NGS)-based test kits tailored to bolster preimplantation genetic testing-aneuploidy (PGT-A). This advancement represents a significant contribution to the realm of in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) research, aiming to enhance the accuracy and efficiency of genetic screening processes.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/preimplantation-genetic-testing-market
Further, in February 2022, The Cooper Companies, Inc.unveiled a notable expansion to their PGT-A testing framework. This enhancement, branded as PGT-Complete, encompasses the integration of Parental QC, Genetic PN check, and Origin of Aneuploidy components. Such additions signify a comprehensive approach towards PGT-A testing, elevating standards in genetic analysis within the context of IVF procedures.
Global Preimplantation Genetic Testing Market Report Segment
By Procedure Type
- Preimplantation Genetic Screening
- Preimplantation Genetic Diagnosis
By Technology
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Fluorescence In Situ Hybridization
- Comparative Genomic Hybridization
- Single-Nucleotide Polymorphism
By Product
- Reagents and Consumables
- Instruments
- Software and Services
By Application
- Aneuploidy
- Structural Chromosomal Abnormalities
- Single Gene Disorders
- X-Linked Disorders
- HLA Typing
- Gender Identification
By End-User
- Fertility Clinics
- Hospitals
- Diagnostic Laboratories
A full report of Preimplantation Genetic Testing Market available @ https://www.omrglobal.com/industry-reports/preimplantation-genetic-testing-market
Preimplantation Genetic Testing Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott Laboratories (Abbott.)
- Agilent Technologies, Inc.
- Beijing Genomics Institute (BGI Group)
- Bioarray S.L.
- California Pacific Medical Center (Indian Health Center of Santa Clara Valley)
- Coopersurgical (CooperSurgical Inc.)
- Genea Pty Ltd.
- Illumina
- Invicta Genetics
- Invitae Corp.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
